Gadoteridol
Records for this ingredient, by country (identity only).
ATC V08CA04 · 8 markets · 28 records
JP 8 records · 6 shown of 6
- 17 mL per mL / per unit basis not statedinjectionガドテリドール静注シリンジ17mL「HK」プロハンス静注シリンジ17mL
- 10 mL per mL / per unit basis not statedinjectionプロハンス静注10mL
- 20 mL per mL / per unit basis not statedinjectionプロハンス静注10mL
- 15 mL per mL / per unit basis not statedinjectionプロハンス静注10mL
- 13 mL per mL / per unit basis not statedinjectionガドテリドール静注シリンジ17mL「HK」プロハンス静注シリンジ17mL
- 5 mL per mL / per unit basis not statedinjectionプロハンス静注10mL
AU 6 records · 1 shown of 1
- 279.3 mg/mL per mL / per unit basis not statedinjectionPROHANCE gadoteridol 2793mg/10mL injection syringePROHANCE gadoteridol 2793mg/10mL injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 5 records · 4 shown of 4
- 17 mL per mL / per unit basis not statedinjectionProHance 0.5mmol/ml solution for injection 10ml pre-filled syringes
- 10 mL per mL / per unit basis not statedinjectionProHance 0.5mmol/ml solution for injection 10ml pre-filled syringesProHance 0.5mmol/ml solution for injection 10ml vials
- 20 mL per mL / per unit basis not statedinjectionProHance 0.5mmol/ml solution for injection 10ml vials
- 15 mL per mL / per unit basis not statedinjectionProHance 0.5mmol/ml solution for injection 10ml vials
US 2 records · 1 shown of 1
- 279.3 mg per mL / per unit basis not statedinjectionProHanceManufacturer: Slate Run Pharmaceuticals, …
ES 2 records · 2 shown of 2
- 279.3 mg per mL / per unit basis not statedinjectionPROHANCE PRECARGADA
- 279.3 mg/1 mLinjectionProHance
FR 2 records · 1 shown of 1
- 279.3 mg/1 mLinjectionPROHANCE 0,5 mmol/mL, solution injectablePROHANCE 0,5 mmol/mL, solution injectable en seringue pré-remplie
CA 1 records · 1 shown of 1
- 279.3 mg per mL / per unit basis not statedliquidProHance
TW 1 records · 1 shown of 1
- 279.3 mg per mL / per unit basis not statedinjectionProHance 279.3 mg/ml solution for infusion普優顯注射液
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | ES | TW | JP | FR |
|---|---|---|---|---|---|---|---|---|
| 279.3 mg per mL / per unit basis not stated cannot compare injection | Manufacturer: Slate Run Pharmaceuticals, … ProHance | PROHANCE PRECARGADA | ProHance 279.3 mg/ml solution for infusion 普優顯 | |||||
| 279.3 mg/1 mL injection | ProHance | PROHANCE 0,5 mmol/mL, solution injectable PROHANCE 0,5 mmol/mL, solution injectable en seringue pré-remplie | ||||||
| 17 mL per mL / per unit basis not stated cannot compare injection | ProHance 0.5mmol/ml solution for injection 10ml pre-filled syringes | ガドテリドール静注シリンジ17mL「HK」 プロハンス静注シリンジ17mL | ||||||
| 10 mL per mL / per unit basis not stated cannot compare injection | ProHance 0.5mmol/ml solution for injection 10ml pre-filled syringes ProHance 0.5mmol/ml solution for injection 10ml vials | プロハンス静注10mL | ||||||
| 279.3 mg/mL per mL / per unit basis not stated cannot compare injection | PROHANCE gadoteridol 2793mg/10mL injection syringe PROHANCE gadoteridol 2793mg/10mL injection vial | |||||||
| 20 mL per mL / per unit basis not stated cannot compare injection | ProHance 0.5mmol/ml solution for injection 10ml vials | プロハンス静注10mL | ||||||
| 15 mL per mL / per unit basis not stated cannot compare injection | ProHance 0.5mmol/ml solution for injection 10ml vials | プロハンス静注10mL | ||||||
| 13 mL per mL / per unit basis not stated cannot compare injection | ガドテリドール静注シリンジ17mL「HK」 プロハンス静注シリンジ17mL | |||||||
| 279.3 mg per mL / per unit basis not stated cannot compare liquid | ProHance | |||||||
| 5 mL per mL / per unit basis not stated cannot compare injection | プロハンス静注10mL | |||||||
unknown | ProHance |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in CA · AU · ES · FR and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en CA · AU · ES · FR que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 CA · AU · ES · FR 有记录(未在本表显示)。 另有 4 個規格/劑型僅在 CA · AU · ES · FR 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.